As one of the key proteins regulating CD8+ T cells, CD155 can inhibit the metabolism of CD8+ T cells through the TIGIT signaling pathway in gastric cancer 29 and inhibit the immune response by inhibiting the function of CD8+ T cell effectors. Here, TIGIT is linked to gastric cancer.